We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: The minimally invasive, cost-effective liquid biopsy offers an accessible alternative to tissue biopsy for tailoring breast cancer treatment strategies (photo credit: 123RF)

Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer

A new liquid biopsy transcriptome assay predicts pembrolizumab response and neoadjuvant outcomes in HER2-negative breast cancer. More...
05 May 2026
Image: Stuart Ibsen, Ph.D., led the team that developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer (Photo courtesy of OHSU/Christine Torres Hicks)

New Blood Test Distinguishes Pancreatic Cancer From Benign Disease

A blood test using tumor-shed nanoparticles differentiates pancreatic cancer from benign disease with 97% accuracy. More...
04 May 2026
Image: Unity Confirm is a circulating fetal cell–based confirmation test designed for use following a high‑risk Unity Aneuploidy Screen result (Photo courtesy of BillionToOne)

Noninvasive Test Confirms High-Risk Prenatal Screening Results from Blood

A new fetal cell–based test confirms high‑risk NIPT for common aneuploidies and 22q11.2 microdeletion. More...
04 May 2026
Image: A machine learning tool, T1GRS, accurately predicts genetic risk of type 1 diabetes in children and adults (Photo courtesy of Adobe Stock)

Machine-Learning Genetic Risk Score Improves Early Prediction of Type 1 Diabetes

An AI-derived genetic risk score improves early type 1 diabetes prediction across populations, enabling broader screening. More...
04 May 2026
Image: Veracyte’s Decipher portfolio is featured in 15+ studies at AUA 2026, highlighting Decipher Bladder subtyping and real-world evidence for Decipher Prostate (Photo courtesy of Veracyte)

Genomic Classifiers Improve Risk Stratification and Treatment Selection in Urologic Cancers

New data show a genomic classifier portfolio refines risk assessment and guides therapy in prostate and bladder cancer. More...
04 May 2026
Image: Schematic of Mpox diagnostic methods.(A) Artificial intelligence (AI)-enhanced image classification can be leveraged to classify lesions concerning for Mpox, particularly in low resource settings where specialists (i.e., infectious disease specialists or dermatologists) are not available. (B) Clinical specimens (including nasal swabs, lesion swabs, or serum samples) can be used for molecular or biochemical confirmation of Mpox infection. (C) Rapidly, field-deployable devices or assays can be developed using various strategies(Mpox) diagnostic methods (Yilgic D, Ergonul O, Tasoglu S. Mpox diagnosis at POC. Trends in Biotechnology. DOI: 0.1016/j.tibtech.2025.04.015)

Point-of-Care Tests Could Expand Access to Mpox Diagnosis

New findings outline POC Mpox tools combining AI lesion triage with rapid assays to speed near-patient detection. More...
03 May 2026
Image: A new CRISPR-based technique enables simultaneous detection of multiple pathogens in a single test (photo courtesy of Shutterstock)

CRISPR-Based Test Identifies Multiple Respiratory Viruses Simultaneously

A new diagnostic technology measures the reaction speed of CRISPR gene scissors, enabling simultaneous identification of multiple viruses and variants. More...
01 May 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Electrolyte Analyzer
BKE-B
Thyroid Test
Anti-Thyroid EIA Test


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.